Latigo Biotherapeutics Inc. carries a market capitalization of 1.19B, placing it among publicly traded companies globally.
| Market Cap | 1.19B |
| Enterprise Value | N/A |
Latigo Biotherapeutics Inc.'s stock has gained approximately 10.20889% over the past 52 weeks. The 50-day moving average sits at 19.08, while the 200-day moving average is 19.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 10.20889% |
| 50-Day Moving Average | 19.08 |
| 200-Day Moving Average | 19.08 |
| Average Volume (20 Days) | N/A |